| Predicate |
Object |
| contentType |
Journal Article |
| issn |
0140-6736 |
| issueIdentifier |
9345 |
| pageRange |
1604; author reply 1605- |
| publicationName |
Lancet (London, England) |
| startingPage |
1604; author reply 1605 |
| bibliographicCitation |
Thaler H, Sim E. Fondaparinux versus enoxaparin for prevention of venous. Lancet. 2002 Nov 16;360(9345):1604; author reply 1605. doi: 10.1016/s0140-6736(02)11541-8. PMID: 12443627. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dad98f80f71e478fb317e1cb0df83db
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df4ea78ee79d293ca93ffba6604df43e |
| date |
2002-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1016/s0140-6736%2802%2911541-8
https://pubmed.ncbi.nlm.nih.gov/12443627 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
https://portal.issn.org/resource/ISSN/0140-6736 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Fondaparinux versus enoxaparin for prevention of venous thromboembolism |
| discusses |
http://id.nlm.nih.gov/mesh/M0017249
http://id.nlm.nih.gov/mesh/M0027160
http://id.nlm.nih.gov/mesh/M0008434
http://id.nlm.nih.gov/mesh/M0403648 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011134Q000008
http://id.nlm.nih.gov/mesh/D017984Q000008
http://id.nlm.nih.gov/mesh/D013923Q000517
http://id.nlm.nih.gov/mesh/D020246Q000517
http://id.nlm.nih.gov/mesh/D011183Q000517
http://id.nlm.nih.gov/mesh/D005343Q000008 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D019644
http://id.nlm.nih.gov/mesh/D000077425
http://id.nlm.nih.gov/mesh/D004334 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772 |